4.4 Letter

Involvement of T2677T multidrug resistance gene polymorphism in Interleukin 22 plasma concentration in B-chronic lymphocytic leukemia patients

Related references

Note: Only part of the references are listed.
Article Oncology

Interleukin 22 Signaling Promotes Cell Growth in Mantle Cell Lymphoma

Pascal Gelebart et al.

TRANSLATIONAL ONCOLOGY (2011)

Article Oncology

Response of malignant B lymphocytes to ionizing radiation: Gene expression and genotype

H Lyng et al.

INTERNATIONAL JOURNAL OF CANCER (2005)

Review Medicine, General & Internal

Mechanisms of disease: Chronic lymphocytic leukemia

N Chiorazzi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, Research & Experimental

Possible prediction of the efficiency of chemotherapy in patients with Lymphoproliferative diseases based on MDR1 gene G2677T and C3435T Polymorphisms

OB Goreva et al.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2003)

Review Genetics & Heredity

Hereditary chronic lymphocytic leukemia: An extended family study and literature review

HT Lynch et al.

AMERICAN JOURNAL OF MEDICAL GENETICS (2002)

Review Oncology

Genetic susceptibility to chronic lymphocytic leukemia

RS Houlston et al.

LEUKEMIA (2002)

Article Hematology

Multildrug resistance mechanisms in chronic lymphocytic leukaemia

U Consoli et al.

BRITISH JOURNAL OF HAEMATOLOGY (2002)

Article Biochemistry & Molecular Biology

Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R

MH Xie et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)

Article Multidisciplinary Sciences

Human interleukin-10-related T cell-derived inducible factor: Molecular cloning and functional characterization as an hepatocyte-stimulating factor

L Dumoutier et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)